BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Pharmacogenetics, Aspirin, rs2476601, LEP, Response to oxidative stress, Lung cancer)
Bookmark Forward

QuickView for TUB1;jsessionid=AC7805F930E5EAEDDAEC0B09FAAE327E;jsessionid=0E40F81B361A8CB1D714B0A13B3D4254;jsessionid=4BF366B5B86665801DD41609629C3ECE (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal brain
  2. Dorsal root ganglia
  3. Whole brain
  4. Temporal lobe
  5. Medulla oblongata
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Finding related to sleep
  2. Epstein-Barr virus disease
  3. Middle East respiratory syndrome
  4. Dermatosis due to mites
  5. Viremia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. domoic acid
  2. NQ Y15
  3. N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine
  4. 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  5. Viral Vaccines
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Mir10a
  2. FAM110B
  3. MECP2
  4. CD46
  5. ABCA4
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Tubulin isotypes optimize distinct spindle positioning mechanisms during yeast mitosis.
  2. The oncogenic role of tubulin alpha-1c chain in human tumours.
  3. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
  4. Nuclear targeted Saccharomyces cerevisiae asparagine synthetases associate with the mitotic spindle …
  5. TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for TUB1;jsessionid=AC7805F930E5EAEDDAEC0B09FAAE327E;jsessionid=0E40F81B361A8CB1D714B0A13B3D4254;jsessionid=4BF366B5B86665801DD41609629C3ECE
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.